Loading the company…
Loading the company…
Families: Tumor ablation.
All companies · Product and company coverage
In the last ten years FDA made 1 decision for Nanjing Devin Medical Technology (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 1 procedure family, the most in 2026 (1). The latest was on 2026-03-02.
| Family | Decisions on record |
|---|---|
| Tumor ablation | 1 |
| Date | Kind | Number | Device |
|---|---|---|---|
| 2026-03-02 | 510(k) | K253771 | Disposable Microwave Ablation Antenna (DW-XR-II1, DW-XR-II3, DW-XR-II4, DW-XR-II14, DW-XR-II5, DW-XR-II6, DW-XR-II7, DW-XR-II8, DW-XR-II9, DW-XR-II10, DW-XR-II18, DW-XR-II19, DW-XR-II20, DW-XR-II21, DW-DG-II6, DW-DG-II7, DW-DG-II9, DW-DG-II10, DW-DG-II13) |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Nanjing Devin Medical Technology.